» Articles » PMID: 35282466

Accurate Location of Catheter Tip With the Free-to-Total Metanephrine Ratio During Adrenal Vein Sampling

Overview
Specialty Endocrinology
Date 2022 Mar 14
PMID 35282466
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The selectivity index (SI) of cortisol is used to document correct catheter placement during adrenal vein sampling (AVS) in patients with primary aldosteronism (PA). We aimed to determine the cutoff values of the SIs based on cortisol, free metanephrine, and the free-to-total metanephrine ratio (FTMR) using an adapted AVS protocol in combination with CT.

Methods: Adults with PA and referred for AVS were recruited in two hypertension centers. The cortisol and free metanephrine-derived SIs were calculated as the concentration of the analyte in adrenal veins divided by the concentration of the analyte in the distal vena cava. The FTMR-derived SI was calculated as the concentration of free metanephrine in the adrenal vein divided by that of total metanephrine in the ipsilateral adrenal vein. The AVS was classified as an unequivocal radiological success (uAVS) if the tip of the catheter was seen in the adrenal vein. The SI cutoffs of each index marker were established using receiver operating characteristic curve analysis.

Results: Out of 125 enrolled patients, 65 patients had an uAVS. The SI cutoffs were 2.6 for cortisol, 10.0 for free metanephrine, 0.31 for the FTMR on the left side, and 2.5, 9.9, and 0.25 on the right side. Compared to free metanephrine and the FTMR, cortisol misclassified AVS as unsuccessful in 36.6% and 39.0% of the cases, respectively.

Conclusion: This study is the first to calculate the SIs of cortisol, free metanephrine, and the FTMR indices for the AVS procedure. It confirms that free metanephrine-based SIs are better than those based on cortisol.

Citing Articles

Discordance between adrenal vein sampling and imaging: the role of unilateral cortisol excess.

Grundy M, Leung A, Hyrcza M, Pasieka J, Chan D, Przybojewski S Eur J Endocrinol. 2025; 192(3):191-201.

PMID: 39960854 PMC: 11894521. DOI: 10.1093/ejendo/lvaf019.


Impact of Cortisol-Cosecretion on Adrenal Venous Sampling Results in Primary Aldosteronism: Study of 225 Cases.

Lamas C, Araujo-Castro M, Ostermair L, Petersenn E, Parra Ramirez P, Rebollo-Roman A Biomedicines. 2024; 12(11).

PMID: 39594996 PMC: 11591640. DOI: 10.3390/biomedicines12112430.


Adrenal Vein Sampling for Primary Aldosteronism: Recommendations From the Australian and New Zealand Working Group.

Yang J, Bell D, Carroll R, Chiang C, Cowley D, Croker E Clin Endocrinol (Oxf). 2024; 102(1):31-43.

PMID: 39360599 PMC: 11612544. DOI: 10.1111/cen.15139.


Imaging or Adrenal Vein Sampling Approach in Primary Aldosteronism? A Patient-Based Approach.

Tizianel I, Sabbadin C, Mian C, Scaroni C, Ceccato F Tomography. 2022; 8(6):2735-2748.

PMID: 36412687 PMC: 9680373. DOI: 10.3390/tomography8060228.

References
1.
Savard S, Amar L, Plouin P, Steichen O . Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2013; 62(2):331-6. DOI: 10.1161/HYPERTENSIONAHA.113.01060. View

2.
Peng K, Liao H, Chan C, Lin W, Yang S, Tsai Y . Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success. Hypertension. 2020; 76(5):1537-1544. DOI: 10.1161/HYPERTENSIONAHA.120.15328. View

3.
Ceolotto G, Antonelli G, Caroccia B, Battistel M, Barbiero G, Plebani M . Comparison of Cortisol, Androstenedione and Metanephrines to Assess Selectivity and Lateralization of Adrenal Vein Sampling in Primary Aldosteronism. J Clin Med. 2021; 10(20). PMC: 8538328. DOI: 10.3390/jcm10204755. View

4.
Eisenhofer G, Rundquist B, Aneman A, Friberg P, Dakak N, Kopin I . Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J Clin Endocrinol Metab. 1995; 80(10):3009-17. DOI: 10.1210/jcem.80.10.7559889. View

5.
Dekkers T, Prejbisz A, Schultze Kool L, Groenewoud H, Velema M, Spiering W . Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial. Lancet Diabetes Endocrinol. 2016; 4(9):739-746. DOI: 10.1016/S2213-8587(16)30100-0. View